Skip to content
Luna Metabolic
Menu

Head-to-head for women

Invigor Medical vs REMEVi

Invigor Medical and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.

Invigor Medical

Ranked #34 for women · Grade B

Best for: Women who want GLP-1 medication alongside a broader hormone and wellness catalog on one account.

Visit Invigor Medical
vs

REMEVi

Higher score

Ranked #31 for women · Grade B

Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.

Visit REMEVi

The verdict for women

Higher Luna Fit Score: REMEVi

REMEVi edges out Invigor Medical on the Luna Fit Score, 85 to 84 (B vs B). Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. The reasoning behind that number is in the REMEVi scorecard.

Invigor Medical is still a genuine option — an established telehealth pharmacy with a broad metabolic and hormone catalog — handy if you want GLP-1 care inside a wider hormonal-wellness program. Weigh the six women's-health factors below against your own priorities; the Invigor Medical scorecard goes through each of them, and if neither of these two is the one, the Invigor Medical alternatives, scored on the same six factors widens the field.

Side-by-side on the six factors

Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.

Invigor Medical REMEVi
PCOS & hormonal suitability8683
Invigor
REMEVi
Clinical oversight & labs8485
Invigor
REMEVi
Price transparency8582
Invigor
REMEVi
Nationwide access8095
Invigor
REMEVi
Ongoing support8683
Invigor
REMEVi
Cancellation fairness8582
Invigor
REMEVi

Price, access & features

DetailInvigor MedicalREMEVi
Luna Fit Score84/100 · B85/100 · B
Overall rank#34#31
Semaglutide$199/mo$199/mo
Tirzepatide$339/mo$269/mo
CoverageNot disclosedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only

Invigor Medical

Ranked #34 · Grade B

What we like

  • Broad hormone and metabolic catalog beyond GLP-1
  • Mid-market pricing on both molecules, both disclosed
  • Long-running operator with clinician oversight

The caveats

  • Does not publish an explicit states-served list
  • Compounded only
  • Catalog breadth over PCOS-specific specialization

REMEVi

Ranked #31 · Grade B

What we like

  • LegitScript-accredited and available in all 50 states
  • Both molecules disclosed, tirzepatide for insulin-resistant PCOS
  • Clear, predictable pricing

The caveats

  • Higher-end pricing — $199 semaglutide, $269 tirzepatide
  • No oral or brand-name option; general program without hormone specialization

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Neither Invigor Medical nor REMEVi is only worth comparing with the other. Invigor Medical is also written up against CoreAge Rx, 9 points apart on the Luna Fit Score — see Invigor Medical against CoreAge Rx, factor by factor. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.

Or browse the full comparison hub.